Use of percutaneous ventricular assist devices (LVADs) among patients with cardiogenic shock following acute MI continues despite a lack of supporting data and evidence of an increase in adverse ...

Centers with multidisciplinary teams created to rapidly respond to cardiogenic shock are more likely to use invasive hemodynamic monitoring and advanced mechanical circulatory support (MCS), but less ...

DALLAS, TX — The contemporary management of cardiogenic shock is the focus of a scientific statement from the American Heart Association (AHA) [1]. Cardiogenic shock is a life-threatening, ...

Despite advances in the treatment of myocardial infarction (MI), the incidence of cardiogenic shock has remained at 7% to 10% during the last 25 years. Hospital mortality was about 90% in the 1970s; ...

Hospitals participating in the National Cardiogenic Shock Initiative (NCSI) produced favorable survival rates for the challenging population of acute MI patients with cardiogenic shock, investigators ...

CHICAGO -- Unexpectedly, early extracorporeal membrane oxygenation (ECMO) did not help outcomes in severe or rapidly progressing cardiogenic shock, the ECMO-CS randomized trial found. What appeared to ...

VitalStream is an FDA-cleared wireless, wearable monitor for continuous blood pressure and advanced hemodynamics. VitalStream tablet application. By simplifying the monitoring process and providing ...

This Review explores contemporary circulatory support in profound postinfarction cardiogenic shock. Frequently, death is the only alternative to implantation of a blood pump, so prospective randomized ...

The results of the Intraaortic Balloon Pump in Cardiogenic Shock (IABP-SHOCK) II trial, presented at the 2012 European Society of Cardiology Congress and published in the New England Journal of ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Early veno-arterial extracorporeal membrane oxygenation for cardiogenic shock did not improve outcomes ...

SUPPORT II (SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)) is a prospective, randomized controlled study designed to assess the safety and efficacy of the ...

Cardiogenic shock occurs when the heart is not able to pump enough blood to generate adequate cardiac output to maintain normal blood pressure. This frequently occurs in the setting of a large ...